Chemoinformaics analysis of 17beta(H),21beta(H)-HOP-22(29)-EN-3-ONE
| Molecular Weight | 424.713 | nRot | 1 |
| Heavy Atom Molecular Weight | 376.329 | nRig | 27 |
| Exact Molecular Weight | 424.371 | nRing | 5 |
| Solubility: LogS | -6.24 | nHRing | 0 |
| Solubility: LogP | 6.625 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 79 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 82.9081 |
| nHD | 0 | BPOL | 49.0219 |
| QED | 0.387 |
| Synth | 4.604 |
| Natural Product Likeliness | 2.581 |
| NR-PPAR-gamma | 0.034 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.257 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -5.13 |
| MDCK | 0.0000101 |
| BBB | 0.102 |
| PPB | 0.954285 |
| VDSS | 1.275 |
| FU | 0.0180539 |
| CYP1A2-inh | 0.073 |
| CYP1A2-sub | 0.607 |
| CYP2c19-inh | 0.108 |
| CYP2c19-sub | 0.973 |
| CYP2c9-inh | 0.17 |
| CYP2c9-sub | 0.787 |
| CYP2d6-inh | 0.13 |
| CYP2d6-sub | 0.889 |
| CYP3a4-inh | 0.521 |
| CYP3a4-sub | 0.578 |
| CL | 5.711 |
| T12 | 0.121 |
| hERG | 0.076 |
| Ames | 0.003 |
| ROA | 0.177 |
| SkinSen | 0.888 |
| Carcinogencity | 0.041 |
| EI | 0.817 |
| Respiratory | 0.962 |
| NR-Aromatase | 0.031 |
| Antiviral | No |
| Prediction | 0.614707 |